Symptom management for irritable bowel syndrome

Symptom management for irritable bowel syndrome : a pilot randomized controlled trial of moxibustion.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002064

Enrollment

Registered

2016-09-19

Start date

2016-10-04

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Intervention group : Subjects were blind-folded, then moxibustion intervention will be applied to Guan Yuan(CV4) using 5 moxibustion plates for 20 minutes. At the same time, infra-

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) between 18 years and 30 years man and woman (2) repeated abdominal pain or discomfort(an uncomfortable sensation not described as pain) at least 3 times per month (3) associated with two or more of the following recent 3 months (a) Improvement with defecation (b) Onset associated with a change in frequency of stool (c) Onset associated with a change in form (appearance) of stool (4) 1 )Bristol Stool Chart Scale 6-7)?25% 2) Bristol Stool Chart Scale 1-2.)?25% (5) if women, negative in urine pregnancy test and agree with not being pregnant during clinical trial (6) not diagnosed with cardiovascular disease like hypertension, diabetes mellitus, hyperlipidemia (7) recently body temperature not being over 38.5 celsius lasting at least 4 hours (8) those who sign in IRB approved consent and agree with clinical trial plan and follow-up observation

Exclusion criteria

Exclusion criteria: (1) Diagnosed with cardiovascular disease (2) had high fever in recent 1 week (3) before clinical trial screening process, if the subject was participated in other clinical trial and administered medication(include placebo) for clinical trial in recent 30days. (4) considered as inappropriate subject by clinical trial researcher.

Design outcomes

Primary

Measure	Time frame
Bowel Symptom Severity Scale(BSSS) score	—

Secondary

Measure	Time frame
Irritable Bowel Syndrome Severity Scale–Korean Version ; temperature difference between Dan Zhong(CV17) and Chung-wan(CV12);Cold-Heat Pattern Questionnaire Score; Qi-stagnation questionnaire score,; visceral sensitivity Questionnaire score;Heart Rate Variability	—

Countries

Korea, Republic of

Contacts

Public ContactSeon Mi Shin

Semyung University

bunggujy21@hanmail.net+82-43-649-1873

Outcome results